Mélanie Thill-Tayara is a competition lawyer based in Paris where she heads the French and European competition law department. She specialises in a variety of sectors including consumer goods, pharmaceuticals and medical devices, chemicals, leisure and luxury goods.
Mélanie focuses on various aspects of EU and French competition law. She has acquired a strong reputation as a litigator and has been involved in landmark cases, for example in the field of essential facilities, dominance abuses in the pharma sector and information exchange systems. Melanie has represented major French and international companies in merger notifications before French and EU competition authorities, as well as in multi-jurisdictional filings.
Mélanie is a member of the International Bar Association, the Association Française de l’Etude de la Concurrence and the Studienvereinigung Kartellrecht. She is a member of the board and executive committee of the Association des Avocats Pratiquant le Droit de la Concurrence (APDC). Mélanie regularly contributes to legal reviews as well as the legal pages of the financial and economic press. She is also a regular speaker at various competition law or sector-specialised conferences.
Before joining us, Mélanie spent 18 years as partner of another leading international law firm. Prior to that she worked for the European Commission, at the Directorate General for Competition for three years, during which she acted in historic cases such as the cement cartels.
Mélanie holds a DEA (post-graduate degree) in business law and private international law from the University of Paris I Panthéon-Sorbonne, a Maîtrise (master’s degree) in International and European law, a Diploma from the Centre Universitaire d’Etudes Communautaires and a Diploma of Political Sciences from the University of Munich. She was admitted to the Paris Bar in 1987. Mélanie speaks French, English, German and Italian.
Nous analysons la décision de l’Autorité de la concurrence rendue à l’encontre de TDF le 5 février 2015, qui met en lumière la double responsabilité pesant sur certa.
June 23, 2015
This article was first published in Getting the Deal Through: Pharmaceutical Antitrust 2015, published in April 2015; contributing editor: Mélanie Thill-Tayara, Nort.
May 15, 2015
Mélanie Thill-Tayara is quoted in an article looking at different ways to deal with regulatory risks.
March 05, 2014
Par un arrêt du 24 avril 2013, la Cour de Cassation a statué en faveur de Medtronic et a fait droit aux arguments développés devant la Cour d’appel de Paris concerna.
September 12, 2013